4581 — Taisho Pharmaceutical Holdings Co Share News
0.000.00%
- ¥704bn
- ¥463bn
- ¥301bn
Table: Taisho Pharmaceutical HD -9-MTH group results
Table: Taisho Pharmaceutical HD -6-MTH group results
2015 6-month group forecast
U.S. FDA approves Johnson & Johnson diabetes drug, canagliflozin
U.S. FDA approves Johnson & Johnson diabetes drug, canagliflozin
U.S. FDA approves Johnson & Johnson diabetes drug, canagliflozin